You just read:

DRG Forecasts New Treatment Options Will Revolutionize the Management Of Hemophilia A and Hemophilia With Inhibitors; Hemophilia B Patients are Relatively Well Served.

News provided by

Decision Resources Group

Dec 01, 2016, 08:45 ET